Foghorn Therapeutics Inc.FHTXNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
10.71%
↑ 102% above average
Average (28q)
-578.28%
Historical baseline
Range
High:750.70%
Low:-17614.29%
Volatility
-3175.8%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 10.71% |
| Q2 2025 | 6.67% |
| Q1 2025 | 3.23% |
| Q4 2024 | 0.00% |
| Q3 2024 | 31.11% |
| Q2 2024 | 23.73% |
| Q1 2024 | -3.51% |
| Q4 2023 | -67.65% |
| Q3 2023 | 51.43% |
| Q2 2023 | 4.11% |
| Q1 2023 | 10.98% |
| Q4 2022 | -46.43% |
| Q3 2022 | 15.15% |
| Q2 2022 | -4.76% |
| Q1 2022 | -113.64% |
| Q4 2021 | 750.70% |
| Q3 2021 | -12.70% |
| Q2 2021 | -1.61% |
| Q1 2021 | -17614.29% |
| Q4 2020 | 99.31% |
| Q3 2020 | 28.17% |
| Q2 2020 | -12.70% |
| Q1 2020 | 8.70% |
| Q4 2019 | -16.95% |
| Q3 2019 | 80.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |